AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 171 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,349 | +32.1% | 431 | +64.5% | 0.00% | – |
| Q2 2023 | $2,536 | -11.7% | 262 | 0.0% | 0.00% | – |
| Q1 2023 | $2,872 | +149.1% | 262 | -1.9% | 0.00% | – |
| Q4 2022 | $1,153 | -97.8% | 267 | -93.3% | 0.00% | -100.0% |
| Q2 2021 | $52,000 | +33.3% | 4,000 | +33.3% | 0.01% | +33.3% |
| Q1 2021 | $39,000 | -29.1% | 3,000 | -25.0% | 0.01% | -30.8% |
| Q4 2020 | $55,000 | +129.2% | 4,000 | +166.7% | 0.01% | +85.7% |
| Q2 2020 | $24,000 | -66.2% | 1,500 | -57.1% | 0.01% | -72.0% |
| Q4 2019 | $71,000 | +787.5% | 3,500 | +133.3% | 0.02% | +733.3% |
| Q3 2019 | $8,000 | -81.0% | 1,500 | -76.9% | 0.00% | -81.2% |
| Q2 2019 | $42,000 | +7.7% | 6,500 | +8.3% | 0.02% | 0.0% |
| Q1 2019 | $39,000 | +200.0% | 6,000 | +200.0% | 0.02% | +166.7% |
| Q4 2018 | $13,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |